FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W349700770> ?p ?o ?g. }

• W349700770 endingPage "2024" @default.
• W349700770 startingPage "2017" @default.
• W349700770 abstract "Abstract To characterize the prodromal phase of adult T-cell leukemia (ATL), a prospective follow-up study was conducted on 50 carriers in a putative pre-ATL state. This state was defined by the presence of molecularly- detectable monoclonal proliferation of human T-lymphotropic virus type I (HTLV-I)-infected T lymphocytes, and the absence of clinical symptoms of leukemia. The median observation time was 50 months. The pre-ATL subjects were divided into two groups according to initial white blood cell (WBC) counts: group A, those with a normal WBC count (9,000/microL) (n = 30), and group B, those with an increased WBC count (9,000 to 15,000) (n = 20). Comparisons were made between the two groups and with a group of 25 patients with chronic ATL (group C) who had WBC counts of more than 15,000. Significant differences in survival rate were found between groups A and B (10-year survival 65.7%) and group C (32.8%) (P < .01), and between group A (10-year survival 90.0%) and group B (52.1%) (P < .05). The incidence of transformation to overt ATL was 10% (3 of 30) in group A and 50% (10 of 20) in group B (P < .01). In six transformed cases (one in A and five in B) we found exactly the same integration sites in pre-ATL and overt ATL phases, confirming the multistep leukemogenesis hypothesized for this disease. However, the pre-ATL subjects could be divided into two distinct prognostic groups based on the initial WBC count; those with good and those with poor prognosis. Although the 10% transformation rate (2.5% annually) in group A seemed to be extremely high compared with that in the general population of HTLV-I carriers (around 0.06% to 0.4% annually), the majority of group A subjects and some in group B showed stable clinical courses without transformation. Further, development of ATL was not observed in four group A subjects with HTLV-I-associated myelopathy (HAM), which is rarely associated with ATL. We propose to call this group of rather benign HTLV-I carriers “HTLV-I carriers with monoclonal proliferation of T lymphocytes (HCMPT).” Thus far we have been unable to identify reliable parameters other than WBC counts that prospectively distinguish HCMPT from the true pre-ATL state, in which there is a high probability of developing ATL. Further clinical and biologic approaches should elucidate the natural history of the HTLV-I carrier state and early events in ATL leukemogenesis." @default.
• W349700770 created "2016-06-24" @default.
• W349700770 creator A5043351607 @default.
• W349700770 creator A5048061147 @default.
• W349700770 creator A5049465924 @default.
• W349700770 creator A5052891033 @default.
• W349700770 creator A5053408146 @default.
• W349700770 creator A5054251126 @default.
• W349700770 creator A5056319535 @default.
• W349700770 creator A5074998675 @default.
• W349700770 creator A5076189021 @default.
• W349700770 creator A5081071954 @default.
• W349700770 date "1993-10-01" @default.
• W349700770 modified "2023-10-16" @default.
• W349700770 title "Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population" @default.
• W349700770 cites W1966528056 @default.
• W349700770 cites W1981664147 @default.
• W349700770 cites W2009621572 @default.
• W349700770 cites W2012332765 @default.
• W349700770 cites W2033115672 @default.
• W349700770 cites W2048022927 @default.
• W349700770 cites W2058350611 @default.
• W349700770 cites W2086143621 @default.
• W349700770 cites W2095383081 @default.
• W349700770 cites W2336865896 @default.
• W349700770 cites W86279991 @default.
• W349700770 doi "https://doi.org/10.1182/blood.v82.7.2017.2017" @default.
• W349700770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8400254" @default.
• W349700770 hasPublicationYear "1993" @default.
• W349700770 type Work @default.
• W349700770 sameAs 349700770 @default.
• W349700770 citedByCount "45" @default.
• W349700770 countsByYear W3497007702012 @default.
• W349700770 countsByYear W3497007702013 @default.
• W349700770 countsByYear W3497007702014 @default.
• W349700770 countsByYear W3497007702017 @default.
• W349700770 countsByYear W3497007702018 @default.
• W349700770 countsByYear W3497007702020 @default.
• W349700770 countsByYear W3497007702022 @default.
• W349700770 crossrefType "journal-article" @default.
• W349700770 hasAuthorship W349700770A5043351607 @default.
• W349700770 hasAuthorship W349700770A5048061147 @default.
• W349700770 hasAuthorship W349700770A5049465924 @default.
• W349700770 hasAuthorship W349700770A5052891033 @default.
• W349700770 hasAuthorship W349700770A5053408146 @default.
• W349700770 hasAuthorship W349700770A5054251126 @default.
• W349700770 hasAuthorship W349700770A5056319535 @default.
• W349700770 hasAuthorship W349700770A5074998675 @default.
• W349700770 hasAuthorship W349700770A5076189021 @default.
• W349700770 hasAuthorship W349700770A5081071954 @default.
• W349700770 hasBestOaLocation W3497007701 @default.
• W349700770 hasConcept C120665830 @default.
• W349700770 hasConcept C121332964 @default.
• W349700770 hasConcept C126322002 @default.
• W349700770 hasConcept C159047783 @default.
• W349700770 hasConcept C159654299 @default.
• W349700770 hasConcept C163864487 @default.
• W349700770 hasConcept C203014093 @default.
• W349700770 hasConcept C2776238826 @default.
• W349700770 hasConcept C2776913467 @default.
• W349700770 hasConcept C2778461978 @default.
• W349700770 hasConcept C2778488018 @default.
• W349700770 hasConcept C542903549 @default.
• W349700770 hasConcept C61511704 @default.
• W349700770 hasConcept C71924100 @default.
• W349700770 hasConcept C86803240 @default.
• W349700770 hasConcept C90924648 @default.
• W349700770 hasConceptScore W349700770C120665830 @default.
• W349700770 hasConceptScore W349700770C121332964 @default.
• W349700770 hasConceptScore W349700770C126322002 @default.
• W349700770 hasConceptScore W349700770C159047783 @default.
• W349700770 hasConceptScore W349700770C159654299 @default.
• W349700770 hasConceptScore W349700770C163864487 @default.
• W349700770 hasConceptScore W349700770C203014093 @default.
• W349700770 hasConceptScore W349700770C2776238826 @default.
• W349700770 hasConceptScore W349700770C2776913467 @default.
• W349700770 hasConceptScore W349700770C2778461978 @default.
• W349700770 hasConceptScore W349700770C2778488018 @default.
• W349700770 hasConceptScore W349700770C542903549 @default.
• W349700770 hasConceptScore W349700770C61511704 @default.
• W349700770 hasConceptScore W349700770C71924100 @default.
• W349700770 hasConceptScore W349700770C86803240 @default.
• W349700770 hasConceptScore W349700770C90924648 @default.
• W349700770 hasIssue "7" @default.
• W349700770 hasLocation W3497007701 @default.
• W349700770 hasOpenAccess W349700770 @default.
• W349700770 hasPrimaryLocation W3497007701 @default.
• W349700770 hasRelatedWork W183350463 @default.
• W349700770 hasRelatedWork W1977296516 @default.
• W349700770 hasRelatedWork W2032965398 @default.
• W349700770 hasRelatedWork W2101266852 @default.
• W349700770 hasRelatedWork W2126095291 @default.
• W349700770 hasRelatedWork W2138510740 @default.
• W349700770 hasRelatedWork W2724371688 @default.
• W349700770 hasRelatedWork W4233645104 @default.
• W349700770 hasRelatedWork W4252140115 @default.
• W349700770 hasRelatedWork W88146136 @default.
• W349700770 hasVolume "82" @default.

• next